Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |